Innovation of Cell and Gene Therapies


In this episode of Breakthrough Economy, we explore the groundbreaking potential of cell and gene therapies and look at what this means for patient outcomes now and in the future. Host Jen Rogers is joined by Ali Urman, Genomic Revolution Analyst at ARK Invest, and Sam Kulkarni, CEO at CRISPR Therapeutics.

Nasdaq Watch

See what's playing at Nasdaq

Watch Now